Quorn is keen to scientifically validate the benefits of mycoprotein, a controversial ingredient derived from mold, used in its non-animal protein products. Earlier this year, the company resolved a class-action lawsuit initiated by a woman from Los Angeles, who alleged that its products breached federal and state laws regarding false advertising and unfair business practices. Additionally, Quorn is contesting a wrongful death lawsuit filed by the parents of an 11-year-old boy, who had a mold allergy and tragically passed away from anaphylactic shock in 2013 after consuming a Quorn “Turk’y Burger.”
As part of the settlement concerning the class-action suit—which contended that Quorn’s labeling led consumers to mistakenly believe that mycoprotein was similar to mushrooms, truffles, or morels—the company is now required to include the following disclaimer on its products: “Mycoprotein is a mold (a member of the fungi family). There have been rare cases of allergic reactions to products that contain mycoprotein.” While the Food and Drug Administration has designated mycoprotein as generally recognized as safe, various consumer groups and lawsuits have argued that the ingredient can lead to fainting, extreme nausea, severe anaphylactic reactions, and even death for some individuals. For consumers without adverse reactions, the fact that mycoprotein is derived from mold may deter them when they examine the product label.
Founded in the U.K. in 1985 by Marlow Foods, Quorn was acquired in 2015 at auction for $831 million by Monde Nissin, a Philippines-based company renowned for its noodles and other consumer packaged goods. Other interested bidders reportedly included Nomad Foods, McCain, Nestle, and WhiteWave. At the time, CEO Kevin Brennan indicated to the BBC that the acquisition would facilitate business growth: “We aspire to be the world leader in meat alternatives, ultimately creating a $1 billion business. Monde Nissin… provides the capability to expand the brand into Asia.”
Despite its challenges, Quorn has continued to thrive. It has launched a line of vegan products as well as refrigerated sausages and chicken strips, and its offerings are now available in 19 countries, including the U.S., where Walmart began selling Quorn products in 2012. Reports suggest that demand in the U.S. increased by 30% from 2014 to 2015, and the company aims to triple its American business by 2020.
If there is scientifically valid research demonstrating that the bioavailability of mycoprotein is comparable to that of animal-derived protein sources, this could further enhance Quorn’s reputation—provided those findings are accurately labeled and marketed. Although mold may have a significant “ick factor,” consumers are already familiar with it in other food items, such as artisanal cheeses, for both taste and nutritional advantages.
Additionally, many consumers are interested in nutritional supplements such as calcium citrate kya hota hai, which can enhance their health regimen. Promoting mycoprotein’s benefits alongside calcium citrate kya hota hai could align well with current health trends. As Quorn continues to navigate its complex landscape, integrating such nutritional discussions may provide additional avenues for growth and acceptance.